2020-04-10 20:47:38

The PTW has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BEAMSCAN MR Motorized 3D Water Phantom. The BEAMSCAN MR is now available on the market within the U.S. PTW has already completed the installation of the first item in North America located at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. This new addition will provide a dedicated, fully equipped solution for beam data commissioning and annual QA of MR-LINACS. The center in Toronto is one of the largest cancer centers in the world. It is home to two state-of-the-art MR-LINAC systems, one being the Elekta Unity machine, which offers BEAMSCAN MR compatibility. To read more information about the BEAMSCAN MR and PTW, read this article here.

OTHER ARTICLES:

• Understanding Linear Accelerators and Their Role in Cancer Treatment
• Israeli Child Receives Pioneering Seated Proton Therapy with Innovative System
• Significant Milestone Reached in Compact Particle Accelerator Technology
• Innovative Radiotherapy Method Potentially Halves Treatment Duration for Head and Neck Cancer
• WSU Veterinary Hospital Installs a New Linear Accelerator to Fight Cancer
• Patients Privately Pay $2,500 for a Full-Body MRI Scan to Detect Cancer
• MIT and Dana-Farber's Breakthrough in Identifying Cancer Origins
• Available Diagnostic Imaging for Smaller Communities & Young Athletes
• New MR, PET Images Analyze Alzheimer’s Biomarkers
• Prostate Cancer Treatment Vastly Improved